2023 Annual Development Strategy Meeting: 2FIRSTS and IEVA

Jan.05.2023
2023 Annual Development Strategy Meeting: 2FIRSTS and IEVA
2FIRSTS and IEVA discussed e-cigarette industry development strategies for 2023 in an online meeting on January 5th, 2023.

On January 5th, 2023, 2FIRSTS and IEVA held an online meeting to discuss their annual development strategy for the year. The attendees included 2FIRSTS CEO Tong Zhao, COO Xiaoyu Guo, International Public Relations Manager Jason Tian, and 2FIRSTS' Chinese and International Editors, Yuhua Hou and Zhuhong Xu, as well as IEVA President Dustin Dahlmann and board members, Finance and Membership Manager Ciprian Boboi, and Media Relations Manager Philip Drögemüller. The agenda for the meeting was as follows:


IEVA is planning to shoot a global documentary about the electronic cigarette industry and sought advice from 2FIRSTS regarding filming and production. Guo Xiaoyu shared his experience as a supervising producer and director of the documentary "20 Years of Atomization" with IEVA, while Zhao Tong added that the documentary would have a positive impact on the industry.


Both parties have engaged in in-depth discussions and research on the commercial feasibility of recycling disposable electronic cigarettes.


Zhao Tong shared the latest regulatory developments and market conditions in the Chinese electronic cigarette industry for 2022 and provided predictions for relevant matters in 2023.


4. 2FIRSTS and IEVA discussed and strengthened their future cooperation plans during their meeting.


During the meeting, IEVA expressed a desire to obtain 2FIRSTS' database of licensed companies, which would aid in the compliant development of the European electronic cigarette industry.


The editor-in-chief of 2FIRSTS also interviewed Cipri regarding the electronic cigarette market in Europe. 2FIRSTS will continue to stay in contact and communicate with IEVA, keeping a close eye on the European electronic cigarette market. With the partnership of IEVA, they will work together to promote the healthy and compliant development of the electronic cigarette industry in China and Europe.


For more news on IEVA and the European electronic cigarette market, please follow 2FIRSTS.


Ieva and 2FIRSTS host seminar in London: Europe is considering stricter regulation of disposable electronic cigarettes, and after three years, the European E-Cigarette Council has met with the European Electronic Cigarette Association again.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s Federal Public Prosecutor’s Office (MPF) and health regulator Anvisa signed a cooperation protocol to strengthen enforcement against electronic smoking devices (DEFs) and expand health-risk awareness campaigns.
Feb.03 by 2FIRSTS.ai
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
Philip Morris Japan (PMJ) announced that it will launch “SENTIA Purple Capsule,” the first capsule-equipped product in its SENTIA lineup dedicated to the heated tobacco “IQOS ILUMA” series, as an early release in Japan. The product will roll out nationwide starting from IQOS Stores, and will enter tobacco retail channels nationwide from April 6.
Mar.03 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.
Mar.09
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan is considering administrative penalties for the use, import, export, production, wholesale and retail sale, and storage for sale of e-cigarettes, including confiscation of products. The proposed amendments were discussed at a parliamentary committee meeting. The draft sets fine ranges for individuals, officials, and legal entities, and introduces a separate fine for vaping in prohibited places and public areas.
Feb.27 by 2FIRSTS.ai
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai